Literature DB >> 17275930

The developing use of heterozygous mutant mouse models in brain monoamine transporter research.

Allan V Kalueff1, Renee F Ren-Patterson, Dennis L Murphy.   

Abstract

5-Hydroxytryptamine (5-HT), dopamine and norepinephrine are important monoamine neurotransmitters implicated in multiple brain mechanisms and regulated by high-affinity transmembrane monoamine transporters. Although knockout mice lacking 5-HT, dopamine or norepinephrine transporters are widely used to assess brain monoamine processes, these models have several methodological limitations. There is mounting evidence that heterozygous mutant mice with reduced (but not abolished) monoamine transporter functions could provide models with greater relevance to the genetics of human disorders, which only rarely involve complete loss-of-function mutations. Here, we discuss why heterozygous mouse models, in addition to knockout mice, might be useful for brain monoamine transporter research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17275930     DOI: 10.1016/j.tips.2007.01.002

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  21 in total

Review 1.  GSK-3β activity and hyperdopamine-dependent behaviors.

Authors:  Yan-Chun Li; Wen-Jun Gao
Journal:  Neurosci Biobehav Rev       Date:  2010-08-18       Impact factor: 8.989

2.  Impaired hypothalamic-pituitary-adrenal axis and its feedback regulation in serotonin transporter knockout mice.

Authors:  Xue Jiang; Jing Wang; Tian Luo; Qian Li
Journal:  Psychoneuroendocrinology       Date:  2008-11-02       Impact factor: 4.905

Review 3.  Refining psychiatric genetics: from 'mouse psychiatry' to understanding complex human disorders.

Authors:  Justin L Laporte; Renee F Ren-Patterson; Dennis L Murphy; Allan V Kalueff
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

4.  High regulatability favors genetic selection in SLC18A2, a vesicular monoamine transporter essential for life.

Authors:  Zhicheng Lin; Ying Zhao; Chee Yeun Chung; Yanhong Zhou; Nian Xiong; Charles E Glatt; Ole Isacson
Journal:  FASEB J       Date:  2010-02-24       Impact factor: 5.191

5.  Novel MPDZ/MUPP1 transgenic and knockdown models confirm Mpdz's role in ethanol withdrawal and support its role in voluntary ethanol consumption.

Authors:  Lauren C Milner; Renee L Shirley; Laura B Kozell; Nicole A Walter; Lauren C Kruse; Noboru H Komiyama; Seth G N Grant; Kari J Buck
Journal:  Addict Biol       Date:  2013-10-10       Impact factor: 4.280

6.  Mice overexpressing the 5-hydroxytryptamine transporter show no alterations in feeding behaviour and increased non-feeding responses to fenfluramine.

Authors:  A Pringle; K A Jennings; S Line; D M Bannerman; S Higgs; T Sharp
Journal:  Psychopharmacology (Berl)       Date:  2008-06-16       Impact factor: 4.530

Review 7.  Behavioral genetic contributions to the study of addiction-related amphetamine effects.

Authors:  Tamara J Phillips; Helen M Kamens; Jeanna M Wheeler
Journal:  Neurosci Biobehav Rev       Date:  2007-11-29       Impact factor: 8.989

Review 8.  How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Authors:  Dennis L Murphy; Meredith A Fox; Kiara R Timpano; Pablo R Moya; Renee Ren-Patterson; Anne M Andrews; Andrew Holmes; Klaus-Peter Lesch; Jens R Wendland
Journal:  Neuropharmacology       Date:  2008-09-11       Impact factor: 5.250

9.  Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus.

Authors:  Jarod Swant; Sanika Chirwa; Gregg Stanwood; Habibeh Khoshbouei
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

10.  Evidence of long-term expression of behavioral sensitization to both cocaine and ethanol in dopamine transporter knockout mice.

Authors:  Elise Morice; Cécile Denis; Bruno Giros; Marika Nosten-Bertrand
Journal:  Psychopharmacology (Berl)       Date:  2009-11-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.